OpenAI's GPT-5.4 Improves Key Drug-Making Reaction

OpenAI has been extending its models into scientific discovery, with prior work in mathematics, physics, and biology. This project moves into medicinal chemistry, a domain where AI ideas must survive contact with real-world laboratory equipment and noise. The work paired GPT-5.4 with Molecule.one's Maria system, showing how a large language model can generate novel and surprising hypotheses.

The result is concrete: a higher-yielding protocol for a challenging reaction. Yet the authors are careful to note its limits. The method does not yet generalize to other reactions or manufacturing scales. Human experts remain essential for steering and validation, and the yield estimates come from a high-throughput platform.

The real test lies ahead. Independent replication and broader substrate testing will determine if this is a genuinely useful advance or a lab-specific artifact. The outcome hinges on whether the effect observed across 10,080 microliter-scale reactions holds up in the hands of other chemists working with diverse molecules.